This study is investigating whether low-dose aspirin (75mg) reduces the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)Until we complete the research, we will not know whether taking aspirin benefits people with CKD, but we believe that the results of this trial will be extremely important for the NHS.If the benefits of aspirin are shown to outweigh the risks, then treatment will be available immediately to about 3 million people with CKD.
By using this site, you agree that we may store and access cookies on your device. Find out about our cookies.
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.